CAS: 1332331-08-4
![3H-1,2,4-Triazol-3-one, 4-[4-(5-benzofuranyl)phenyl]-5-[[(3S)-1-(cyclopropylcarbonyl)-3-pyrrolidin…](https://static.cymitquimica.com/products/IN/thumb/DA0014FS.jpg)
3H-1,2,4-Triazol-3-one, 4-[4-(5-benzofuranyl)phenyl]-5-[[(3S)-1-(cyclopropylcarbonyl)-3-pyrrolidinyl]methyl]-2,4-dihydro-
CAS:1332331-08-4
Formula:
C25H24N4O3
Purity:
97%
Color and Shape:
Solid
Molecular weight:
428.4831
Ref: IN-DA0014FS
| 2mg | 151.00 € | ||
| 5mg | 299.00 € | ||
| 10mg | 496.00 € | ||
| 25mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
GSK2194069
CAS:1332331-08-4
GSK2194069: Fatty acid synthase inhibitor, β-keto reductase-specific, IC50 7.7 nM, hampers cancer cell proliferation.
Formula:
C25H24N4O3
Purity:
99.84%
Color and Shape:
Solid
Molecular weight:
428.48
Ref: TM-T15429
| 2mg | 147.00 € |
Estimated delivery in United States, on Thursday 23 Jan 2025
(S)-4-(4-(Benzofuran-5-yl)phenyl)-3-((1-(cyclopropanecarbonyl)pyrrolidin-3-yl)methyl)-1H-1,2,4-triazol-5(4H)-one
CAS:1332331-08-4
Versatile small molecule scaffold
Formula:
C25H24N4O3
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
428.49 g/mol
Ref: 3D-HDC33108
| 50mg | 1,633.00 € | ||
| 500mg | 5,320.00 € |
Estimated delivery in United States, on Monday 3 Mar 2025
